Drug Type Cell therapy |
Synonyms- |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedIND Application |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autistic Disorder | IND Application | United States | 01 Feb 2025 | |
Muscular Dystrophy, Duchenne | IND Application | United States | 01 Feb 2025 | |
Crohn Disease | Preclinical | United States | 01 Nov 2024 |